Company News

Polaris Group Has Entered Into An Agreement With The University Of California,Irvine(UCI) To Develop A Universal Influenza And Coronavirus Vaccine.

Polaris Group has entered into an agreement with the University of California,Irvine(UCI) to develop a universal influenza and coronavirus vaccine. This collaboration will use the mRNA vaccine technology developed in the laboratory of Dr. Philip Felgner, who is the head of the UCI Vaccine Research and Development Center, the only integrated program in Vaccine Science in the University of California system. Their expertise ranges from mRNA vaccine development and manufacture through preclinical immune testing and efficacy studies, including competence in using lipids to enhance the activity of a vaccine. A major aim of this collaboration will be to establish that combining the vaccines does not compromise efficacy against the individual components directed against influenza and coronavirus.

Scroll to Top